WPD Pharmaceuticals Inc.
WPDPF
$0.00
-$0.025-100.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.00K | -104.80K | -149.40K | -60.60K | 4.39M |
| Total Depreciation and Amortization | 8.10K | 8.70K | 6.70K | 4.70K | 7.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -241.20K | -153.00K | -103.00K | -114.40K | -3.28M |
| Change in Net Operating Assets | 112.40K | 111.50K | 53.50K | 18.30K | -1.78M |
| Cash from Operations | -126.80K | -137.60K | -192.30K | -152.10K | -656.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -149.30K |
| Other Investing Activities | 5.40K | -- | -- | -- | -10.30K |
| Cash from Investing | 5.40K | -- | -- | -- | -159.60K |
| Total Debt Issued | -2.30K | -32.80K | 267.20K | 267.20K | 300.00K |
| Total Debt Repaid | -- | -- | -- | -- | -2.40K |
| Issuance of Common Stock | -- | -- | -- | -- | 503.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 32.80K | 0.00 | 0.00 | 0.00 | -32.80K |
| Cash from Financing | 22.40K | -24.50K | 198.80K | 213.60K | 582.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 209.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -14.90K | -100.00 | -100.00 |
| Net Change in Cash | -99.00K | -162.10K | -8.30K | 46.70K | -38.60K |
